Organometallics
Article
General Procedure for the Enantioselective Aza-Claisen
Rearrangement. Silver p-toluenesulfonate (4.00 equiv) was dissolved
in MeCN (0.1 mL/mg), and the solvent was subsequently removed by
a stream of dinitrogen. A solution of [FBIPP-Cl]2 (1.00 equiv) in
DCM (0.1 mL/mg) was then added under a dinitrogen atmosphere.
The mixture was stirred overnight at room temperature and
subsequently filtered through Celite/CaH2. The filter cake was
extracted with DCM until the organic solution was colorless. The
solvent was removed by a steady stream of dinitrogen and finally by
high vacuum. A stem solution of the activated catalyst was prepared by
dissolving the solid in dry CHCl3 (20 mmol/L). The required amount
of this solution was added to the substrate (prepared according to
Overman et al.20a) under a nitrogen atmosphere. The reaction tube
was sealed, and the reaction mixture was stirred for the indicated time
at the indicated temperature. Afterwards, the reaction mixture was
suspended in petroleum ether/ethyl acetate (10/1) and subsequently
purified by filtration over silica gel.
H), 6.69 (d, J = 7.5, 2H, arom H), 6.45 (d, J = 2.7, 2H, arom H), 5.58
(m, 1H, Cp ), 5.55 (d, J = 2.7, 1H, Cp H), 5.51 (d, J = 2.7, 1H,
CHPh), 5.35 (d, J = 2.7, 1H, CHPh), 5.22 (d, J = 3.3, 1H, CHPh),
5.10 (d, J = 2.7, 2H, CHPh, Cp H), 4.94 (m, 1H, Cp H), 4.68 (m, 1H,
Cp H), 4.62 (dd, J = 2.7, J = 2.4, 1H, Cp H), 4.34 (m, 1H, Cp H), 2.45
(s, 3H, Ts-CH3), 2.33 (s, 3H, Ts-CH3). All further data are in
accordance with the literature.2
Bis{[μ-chloro-[(η5-(4′′R,5′′R)-(1-SP)-2-(2′′-4′′,5′′-dihydro-
4′′,5′′-diphenyl-1′′-tosyl-1′′H-imidazolyl)cyclopentadienyl-
κC1,κN3]palladium(II)][μ-chloro-[(η5-(4′′′R,5′′′R)-(1′-SP)-2′-(2′′′-
4′′′,5′′′-dihydro-4′′′,5′′′-diphenyl-1′′′-tosyl-1′′′H-imidazolyl)-
cyclopentadienyl-κC1′,κN3′]platinum(II)]iron(II)} ([FBIPP-Cl]2).
A mixture of platinacycles 1/12 (249.1 mg, 0.214 mmol, 1.00 equiv),
bis(acetonitrile)dichloropalladium (55.5 mg, 0.214 mmol, 1.00 equiv),
and sodium acetate (34.0 mg, 0.428 mmol, 2.00 equiv) was dissolved
in degassed 1,2-dichloroethane/tBuOH (1/1) (28.5 mL) and the
solution stirred for 7.5 h at 80 °C. After the mixture was cooled to
room temperature, the solvent was removed in vacuo and the reaction
mixture was filtered through silica gel (DCM). The solvent was
subsequently removed under reduced pressure. The product was
obtained as a red solid (161.1 mg, 0.0617 mmol, 58%). The product is
a mixture of two regioisomers (isomeric ratio 1/0.5). [α]D25 (c = 0.020
[FBIP-Cl]2 was prepared according to literature procedures.4
trans-N,N-μ-[(1S)-2-[(4R,5R)-1-(4-Tolylsulfonyl)-4,5-dihydro-
4,5-diphenyl-1H-imidazol-2-yl-κN3]-1′-[(4R,5R)-1-(4-tolylsul-
fonyl)-4,5-dihydro-4,5-diphenyl-1H-imidazol-2-yl-κN3]-1-ferro-
cene-κC1]chloroplatinum(II) (1) and Bis[(1S)-2-[(4R,5R)-1-(4-
tolylsulfonyl)-4,5-dihydro-4,5-diphenyl-1H-imidazol-2-yl-κN3]-
1′-[(4R,5R)-1-(4-tolylsulfonyl)-4,5-dihydro-4,5-diphenyl-1H-
imidazol-2-yl]-1-ferrocene-κC1]-μ-dichlorodiplatinum(II) (12).
(4′′R,5′′R)-1,1'-Bis(2′′-4′′,5′′-dihydro-4′′,5′′-diphenyl-1′′-
tosylimidazolyl)ferrocene4 (FBI; 200.0 mg, 0.214 mmol, 1.00 equiv)
was suspended in benzene (2.20 mL). To this mixture was added a
solution of K[(C2H4)PtCl3] (157.7 mg, 0.428 mmol, 2.00 equiv) and
sodium acetate (70.2 mg, 0.856 mmol, 4.00 equiv) in methanol (2.20
mL), and the resulting solution was stirred for 24 h at room
temperature. Afterwards the reaction mixture was filtered through
Al2O3 (ethyl acetate). Solvent removal under reduced pressure yielded
the product as a red solid (249.1 mg, 0.214 mmol, 100%). This
product is a mixture of the cis/trans dimeric and the monomeric
species 12 and 1 (4.2/1), respectively, mp > 250 °C dec. Data for
1
g/dL, CHCl3) = −225.0°. Mp: >200 °C dec. H NMR (500 MHz,
CD2Cl2, main isomer (*), minor isomer (#)): δ 7.44−7.36 (m, 12H,
arom H), 7.34−7.11 (m, 20H, arom H), 7.06−6.90 (m, 13H, arom H),
6.90−6.84 (m, 3H, arom H), 6.36−6.30 (m, 4H, arom H), 5.14* (d, J
= 2.2, 1H, Cp H), 6.34 (d, J = 7.7, 4H, arom H), 5.12# (d, J = 2.2, 1H,
Cp H), 5.06−5.03 (m, 2H, Cp H), 4.97* (d, J = 2.8, 1H, CHPh),
4.91# (d, J = 3.1, 1H, CHPh), 4.88# (d, J = 3.5, 1H, CHPh), 4.81* (d,
J = 3.8, 1H, CHPh), 4.66−4.63 (m, 2H, CHPh/Cp H), 4.60* (d, J =
2.8, 1H, CHPh), 4.56−4.53# (m, 2H, CHPh/Cp H), 4.49* (d, J = 3.9,
1H, CHPh/Cp H), 4.48−4.46* (m, 1H, Cp H), 4.46−4.44# (m, 1H,
Cp H), 4.38 (d, J = 2.4, 1H, Cp H), 4.37* (d, J = 2.4, 1H, Cp H),
4.29# (d, J = 2.2, 1H, Cp H), 4.27* (d, J = 2.2, 1H, Cp H), 2.41 (s, 3H,
Ts-CH3), 2.39 (s, 3H, Ts-CH3), 2.37 (s, 3H, Ts-CH3). 13C NMR (500
MHz, CD2Cl2): δ 172.3 (2C), 170.4 (2C), 145.8 (2C), 145.6 (2C),
140.9, 140.7 (2C), 140.5 (2C), 140.3, 134.1, 133.9 (2C), 133.8 (2C),
133.7, 130.3 (4C), 130.2 (4C), 129.6 (4C), 129.5 (4C), 128.9, 128.8,
128.7 (2C), 128.6, 128.5, 128.4 (2C), 127.6, 127.3, 127.2 (2C), 127.1,
127.0 (2C), 126.9 (3C), 126.6, 126.5 (2C), 125.7, 125.6 (2C), 125.5
(2C), 125.4, 126.2 (2C), 97.9 (2C), 97.2, 78.1 (2C), 77.7, 77.5, 77.3
(2C), 76.7 (2C), 76.4 (2C), 75.8, 75.5, 74.9 (2C), 74.7 (2C), 74.4
(2C), 73.3, 73.1 (2C), 73.0 (2C), 72.9 (2C), 71.2, 70.9, 70.0 (2C),
1
dimer 12 are as follows. H NMR (300 MHz, CDCl3, mixture of cis
and trans isomers): δ 7.80−6.53 (m, 82H, arom H), 6.38 (d, J = 7.4,
2H, arom H), 5.58 (d, J = 2.4, 1H, Cp H/CHPh), 5.53−5.49 (m, 1H,
Cp H/CHPh), 5.48 (d, J = 2.7, 1H, Cp H/CHPh), 5.44 (d, J = 2.7,
1H, Cp H/CHPh), 5.37−5.35 (m, 1H, Cp H/CHPh), 5.32 (d, J = 2.7,
1H, Cp H/CHPh), 5.27 (d, J = 2.7, 1H, Cp H/CHPh), 5.17−5.13 (m,
1H, Cp H/CHPh), 5.02 (d, J = 2.7, 2H, Cp H/CHPh), 4.98 (d, J =
3.8, 3H, CHPh), 4.96−4.94 (m, 2H, Cp H/CHPh), 4.92 (d, J = 3.8,
2H, CHPh), 4.87−4.85 (m, 1H, Cp H/CHPh), 4.78−4.73 (m, 1H, Cp
H/CHPh), 4.63−4.59 (m, 2H, Cp H/CHPh), 4.59−4.57 (m, 1H, Cp
H/CHPh), 4.56−4.51 (m, 2H, Cp H/CHPh), 4.48−4.40 (m, 3H, Cp
H/CHPh), 4.33−4.29 (m, 1H, Cp H/CHPh), 4.27 (d, J = 2.4, 2H, Cp
H/CHPh), 4.15−4.09 (m, 2H, Cp H/CHPh), 2.37 (s, 6H, 2 × CH3),
2.34 (s, 3H, CH3), 2.31 (s, 3H, CH3), 2.29 (s, 3H, CH3), 2.25 (s, 3H,
CH3). 13C NMR (75 MHz, CDCl3, mixture of cis and trans isomers): δ
183.8 (qC), 176.89 (qC), 171.0 (qC), 166.5 (qC), 163.3 (qC), 158.3
(qC), 146.0, 145.9, 145.2, 145.0, 144.5, 142.5, 141.1, 140.7, 140.6,
140.1, 139.7, 138.7, 134.5, 134.23, 134.20, 133.2, 130.4, 130.3, 130.1,
130.00, 129.97, 129.8, 129.61, 129.56, 129.53, 129.41, 129.39, 129.32,
129.30, 129.26, 129.1, 129.0, 128.9, 128.82, 128.77, 128.72, 128.67,
128.60, 128.57, 128.54, 128.52, 128.47, 128.3, 128.21, 128.17, 128.0,
127.9, 127.7, 127.64, 127.61, 127.59, 127.5, 127.4, 127.32, 127.27,
127.17, 127.1, 126.78, 126.76, 126.4, 125.94, 125.89, 125.87, 125.84,
125.77, 125.63, 125.57, 125.4, 125.1 (CAr), 85.3, 83.1, 82.7, 80.0, 78.1,
78.0, 77.3, 76.9, 76.8, 76.5, 76.1, 76.0, 75.7, 75.3, 74.7, 74.4, 74.3,
74.19, 74.16, 73.5, 73.3, 73.0, 72.9, 72.49, 72.45, 72.36, 72.2, 71.9,
70.84, 70.78, 67.7 (Cp C/HC(N)), 31.0, 21.77, 21.72, 21.68, 21.62,
̃
69.9, 69.0, 68.9 (2C), 68.5 (2C), 21.4 (4C). IR (in CDCl3): ν 3065,
2925, 2362, 2256, 1597, 1551, 1494, 1457, 1362, 1335, 1259, 1170,
1096, 1029, 971, 905, 812, 728, 670, 649, 607, 545 cm−1. MS (ESI):
m/z 2610.04 (100%, [M]+), 1305.00 (51%, [M + H]+). HRMS (ESI):
m/z calcd for [M]+ 2610.0433, found 2610.0427.
{Acetonitrile-[(η5-(4′′R,5′′R)-(1-SP)-2-(2′′-4′′,5′′-dihydro-
4′′,5′′-diphenyl-1′′-tosyl-1′′H-imidazolyl)cyclopentadienyl-
κC1,κN3]heptafluorobutyratopalladium(II)]}{acetonitrile-[(η5-
(4′′′R,5′′′R)-(1′-SP)-2′-(2′′′-4′′′,5′′′-dihydro-4′′′,5′′′-diphenyl-
1′′′ tosyl-1′′′H-imidazolyl)cyclopentadienyl-κC1',κN3']-
heptafluorobutyratoplatinum(II)]}iron(II) (FBIPP-O2CC3F7). A
solution of silver heptafluorobutyrate (4.9 mg, 0.0153 mmol, 4.00
equiv) in MeCN (0.1 mL) was added to [FBIPP-Cl]2 (10.0 mg, 3.83
μmol, 1.00 equiv) under an N2 atmosphere. The mixture was stirred
for 2 h at room temperature. The reaction mixture was then filtered
through Celite, and subsequently the solvent was removed by a stream
22
of N2 and finally by vacuum. [α]D (c = 0.050 g/dL, CHCl3) =
1
+540.0°. Mp: >200 °C dec. H NMR (500 MHz, CDCl3): δ 7.63−
6.98 (m, 24H, arom H), 6.61−6.56 (m, 2H, arom H), 6.56−6.50 (m,
2H, arom H), 5.83−5.77 (m, 1H, CHPh), 5.61−5.55 (m, 1H, CHPh),
5.19−5.14 (m, 1H, CHPh), 5.16−5.13 (m, 1H, Cp H), 5.11−5.07 (m,
1H, Cp H), 5.00−4.96 (m, 1H, Cp H), 4.92−4.88 (m, 1H, Cp H),
4.86−4.80 (m, 2H, Cp H), 4.67−4.62 (m, 1H, Cp H), 4.55−4.53 (m,
1H, CHPh), 2.49 (s, 3H, Ts-CH3), 2.46 (s, 3H, Ts-CH3), 2.01 (s, 3H,
NCCH3 + 2 × solvent NCCH3), 1.73 (s, 3H, NCCH3). 13C NMR
(500 MHz, CD2Cl2): δ 174.7, 172.0, 147.2, 146.9, 140.8, 140.3, 139.9,
139.7, 134.6, 134.4, 131.3, 131.15 (2C), 131.07 (2C), 130.2 (2C),
130.0 (4C), 129.7 (2C), 129.6 (2C), 129.3 (4C), 128.6, 128.4, 128.0
̃
21.59, 21.49 (Ts-CH3). IR (in CDCl3): ν 3033, 2254, 1971, 1596,
1531, 1495, 1453, 1367, 1170, 1090, 1028 cm−1. MS (ESI, only
monomeric species detectable): m/z 1129.19 (100%, [M + H − Cl]+),
935.23 (3%, [M + H − PtCl]+). HRMS (ESI): m/z calcd for [M + H
− Cl]+ 1129.1889, measd 1129.1886. Data for monomer 1 are as
1
follows. H NMR (300 MHz, CDCl3): δ 7.60−7.31 (m, 16H, arom
H), 7.17 (m, 3H, arom H), 7.01 (m, 5H, arom H), 6.89 (m, 2H, arom
6371
dx.doi.org/10.1021/om300600v | Organometallics 2012, 31, 6365−6372